Skip to main content

Peer Review reports

From: Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)

Original Submission
23 Mar 2022 Submitted Original manuscript
25 Apr 2022 Reviewed Reviewer Report
25 Apr 2022 Reviewed Reviewer Report
10 May 2022 Author responded Author comments - Andrew Bassim Hassan
Resubmission - Version 2
10 May 2022 Submitted Manuscript version 2
18 May 2022 Reviewed Reviewer Report
19 May 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
19 May 2022 Editorially accepted
8 Jun 2022 Article published 10.1186/s12885-022-09697-9

You can find further information about peer review here.

Back to article page